Skip to content

Other expenses at other companies

Renasant logo
RenasantRNST
$17.7M+23.7%
First BanCorp logo
First BanCorpFBP
$6.36M-30.5%
KEE
Keel Infrastructure Corp. Common StockKEEL
$6.15M+2,788%
Denali Therapeutics Inc. logo
Denali Therapeutics Inc.DNLI
$137.36M-5.6%
Grand Canyon Education logo
Grand Canyon EducationLOPE
0.3%+0.2pp
Extreme Networks logo
Extreme NetworksEXTR
$178.2M+8.0%

Other financials

Income statement

See full
Revenue$3.0M-60.9%
Operating income-$78.6M+7.4%
Net income-$73.3M+4.9%
EPS (diluted)-$0.41+10.9%

Balance sheet

See full
Cash & equivalents$204.6M+119%
Total debt$31.6M-33.1%
Total equity$642.2M-10.9%
Total assets$699.6M-12.5%

Cash flow

See full
Operating cash flow-$51.1M+30.2%
CapEx$1.0K
Free cash flow-$44.9M+22.5%

Valuation

See full
Market cap$3.8B+300%

Profitability

See full
Operating margin-2,776.6%-820pp
Net margin-2,554.1%-745pp
FCF margin-1,536%-429pp

Returns & leverage

See full
Return on equity-40%-4.3pp
Debt / equity0.0×
Current ratio22.1×+2.2×

Where this comes from

Reported directly by Relay Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherExpenses.

The official record: Relay Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Relay Therapeutics, Inc.'s other expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Relay Therapeutics, Inc.'s other expenses?
Relay Therapeutics, Inc. (RLAY) reported other expenses of $53K in Q1 2026.